Compare POET & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POET | CLOV |
|---|---|---|
| Founded | 1972 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 959.0M | 1.1B |
| IPO Year | 2008 | 2020 |
| Metric | POET | CLOV |
|---|---|---|
| Price | $6.85 | $1.98 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.07 |
| AVG Volume (30 Days) | ★ 6.2M | 4.7M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,924,308,000.00 |
| Revenue This Year | $2,939.08 | $47.80 |
| Revenue Next Year | $710.17 | $12.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40.34 |
| 52 Week Low | $3.10 | $1.92 |
| 52 Week High | $9.41 | $3.92 |
| Indicator | POET | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 54.76 | 42.42 |
| Support Level | $6.88 | $1.98 |
| Resistance Level | $7.42 | $2.81 |
| Average True Range (ATR) | 0.61 | 0.10 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 48.31 | 19.70 |
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.